ESSA PHARMA INC's ticker is EPIX and the CUSIP is 29668H708. A total of 35 filers reported holding ESSA PHARMA INC in Q3 2023. The put-call ratio across all filers is 5.20 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $519,275 | +14.4% | 168,050 | 0.0% | 0.00% | – |
| Q2 2023 | $453,735 | -11.3% | 168,050 | -2.4% | 0.00% | -100.0% |
| Q1 2023 | $511,496 | -18.9% | 172,221 | -31.2% | 0.00% | 0.0% |
| Q4 2022 | $630,970 | -30.7% | 250,385 | -49.9% | 0.00% | 0.0% |
| Q3 2022 | $910,000 | -15.2% | 499,833 | +46.7% | 0.00% | 0.0% |
| Q2 2022 | $1,073,000 | -42.3% | 340,626 | +13.2% | 0.00% | -50.0% |
| Q1 2022 | $1,859,000 | -2.7% | 300,792 | +123.6% | 0.00% | 0.0% |
| Q4 2021 | $1,910,000 | -24.4% | 134,514 | -57.4% | 0.00% | 0.0% |
| Q3 2021 | $2,526,000 | – | 315,731 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Soleus Capital Management, L.P. | 4,145,117 | $12,310,997 | 1.28% |
| BVF INC/IL | 8,748,629 | $25,983,428 | 0.95% |
| Ally Bridge Group (NY) LLC | 236,583 | $702,652 | 0.92% |
| PFM Health Sciences, LP | 4,161,461 | $12,359,539 | 0.55% |
| Bellevue Group AG | 7,898,583 | $23,458,792 | 0.34% |
| Rhenman & Partners Asset Management AB | 356,500 | $1,051,675 | 0.12% |
| Orbimed Advisors | 1,198,337 | $3,559,061 | 0.07% |
| Privium Fund Management (UK) Ltd | 20,032 | $61,498 | 0.05% |
| Rock Springs Capital Management LP | 524,944 | $1,559,084 | 0.04% |
| Hunting Hill Global Capital, LLC | 10,000 | $29,700 | 0.02% |